A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Chen, WenYong, Ph.D. Bookmark and Share

Laboratory of WenYong Chen, Ph.D.

DNA methylation and histone modification affect mammalian gene regulations and functions. These epigenetic modifications play important roles in many normal biological processes, such as development, stem cell differentiation and aging, as well as in several mental retardation diseases and cancer. Cancer evolves with the genetic loss of function of tumor suppressor genes and overactivity of oncogenes. Meanwhile, cancer progression also involves profound epigenetic deregulation of tumor suppressor genes, and chromatin alterations that affect genomic stability and gene expression. We are interested in understanding the biology of cancer with a focus on epigenetic regulation of tumor suppressor genes and oncogenes in development, aging and tumorigenesis, and developing mouse models for studying cancer epigenetics and testing strategies for cancer prevention and therapy.
Using mouse genetics, we demonstrate the important roles of an epigenetically regulated gene, hypermethylated in cancer 1(HIC1), in tumor suppression. We show that a key role for loss of HIC1 function in tumorigenesis is to activate the mammalian stress-response gene SIRT1 (an NAD-dependent protein deacetylase) and thereby deacetylate and inactivate p53. SIRT1 is a homologue of yeast Sir2 protein, a histone deacetylase that is involved in epigenetic gene silencing, suppression of recombination and maintenance of chromatin functions. SIRT1 protects mammalian cells from apoptosis under stress and DNA damage. Since aging increases promoter hypermethylation and epigenetic silencing of HIC1, these studies suggest that the resultant upregulation of SIRT1 may be a double-edged sword that both promotes survival of aging cells and increases cancer risk in mammals.
SIRT1 over-expression is prevalent in human and mouse cancers; however, the precise roles of SIRT1 in tumorigenesis are not well defined. Other members of the SIRT1 gene family termed sirtuins may also regulate cell metabolism and aging, but their functions in cancer are not well understood. The current research themes in the lab include investigating the roles of SIRT1 in BCR-ABL transformation of primitive hematopoietic progenitor cells and chemoresistance of chronic myelogenous leukemia to tyrosine kinase inhibitors, and studying the functions of sirtuins and NAD metabolism in epithelial cells and carcinogenesis. Our goals are to discern how sirtuins are involved in regulating cellular longevity and tumorigenesis and to develop strategies for healthy aging and reduced cancer risk.
 
For more information on Dr. Chen, please click here.

Chen, WenYong, Ph.D.

Laboratory of WenYong Chen, Ph.D.

DNA methylation and histone modification affect mammalian gene regulations and functions. These epigenetic modifications play important roles in many normal biological processes, such as development, stem cell differentiation and aging, as well as in several mental retardation diseases and cancer. Cancer evolves with the genetic loss of function of tumor suppressor genes and overactivity of oncogenes. Meanwhile, cancer progression also involves profound epigenetic deregulation of tumor suppressor genes, and chromatin alterations that affect genomic stability and gene expression. We are interested in understanding the biology of cancer with a focus on epigenetic regulation of tumor suppressor genes and oncogenes in development, aging and tumorigenesis, and developing mouse models for studying cancer epigenetics and testing strategies for cancer prevention and therapy.
Using mouse genetics, we demonstrate the important roles of an epigenetically regulated gene, hypermethylated in cancer 1(HIC1), in tumor suppression. We show that a key role for loss of HIC1 function in tumorigenesis is to activate the mammalian stress-response gene SIRT1 (an NAD-dependent protein deacetylase) and thereby deacetylate and inactivate p53. SIRT1 is a homologue of yeast Sir2 protein, a histone deacetylase that is involved in epigenetic gene silencing, suppression of recombination and maintenance of chromatin functions. SIRT1 protects mammalian cells from apoptosis under stress and DNA damage. Since aging increases promoter hypermethylation and epigenetic silencing of HIC1, these studies suggest that the resultant upregulation of SIRT1 may be a double-edged sword that both promotes survival of aging cells and increases cancer risk in mammals.
SIRT1 over-expression is prevalent in human and mouse cancers; however, the precise roles of SIRT1 in tumorigenesis are not well defined. Other members of the SIRT1 gene family termed sirtuins may also regulate cell metabolism and aging, but their functions in cancer are not well understood. The current research themes in the lab include investigating the roles of SIRT1 in BCR-ABL transformation of primitive hematopoietic progenitor cells and chemoresistance of chronic myelogenous leukemia to tyrosine kinase inhibitors, and studying the functions of sirtuins and NAD metabolism in epithelial cells and carcinogenesis. Our goals are to discern how sirtuins are involved in regulating cellular longevity and tumorigenesis and to develop strategies for healthy aging and reduced cancer risk.
 
For more information on Dr. Chen, please click here.
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...
  • Don’t kid yourself. Just because it’s mid-January doesn’t mean it’s too late to make resolutions for a happier, and healthier, 2015. Just consider them resolutions that are more mature than those giddy, sometimes self-deluded, Jan. 1 resolutions. To that end, we share some advice from Cary A. Presant, M.D., an ...
  • Sales and marketing executive Jim Murphy first came to City of Hope in 2002 to donate blood for a friend who was being treated for esophageal cancer. The disease is serious. Although esophageal cancer accounts for only about 1 percent of cancer diagnoses in the U.S., only about 20 percent of patients survive at...
  • Aaron Bomar and his family were celebrating his daughter’s 33rd birthday in September 2014 when he received alarming news: According to an X-ray taken earlier that day at an urgent care facility, he had a node on his aorta and was in danger of an aneurysm. Bomar held hands with his wife and daughter and s...
  • Explaining a prostate cancer diagnosis to a young child can be difficult — especially when the cancer is incurable. But conveying the need for prostate cancer research, as it turns out, is easily done. And that leads to action. Earlier this year, Gerald Rustad, 71, who is living with a very aggressive form of m...
  • Cancer and its treatment can create unexpected daily challenges for patients. Side effects from chemotherapy, surgery and radiation therapy as well as the disease itself can cause difficulty in everything from speech to movement to eating. When this happens, rehabilitation is vital; it helps patients restore th...
  • Betsy Sauer and her four daughters share plenty in common. They’re smart and successful.  They’re funny, ranging from wryly witty to wickedly hilarious. Their hobbies tend toward the active and adventurous: hiking, rock climbing, skiing, swimming, fishing, kayaking, yoga and horseback riding. Also, they take he...
  • Flu season is upon us, and few people should take the risk of infection more seriously than cancer patients and their loved ones and caregivers. With the federal Centers for Disease Control and Prevention warning of widespread influenza outbreaks, it’s clear that flu season – and the associated risks – won’t en...
  • HIV/AIDS researchers are determined not only to cure the disease, but to develop ever-more-effective treatments until that ultimate goal is reached. In 2015, they will gain ground in both endeavors. In search of a cure: Stem cell and gene therapy One of the most promising prospects for curing HIV is to recreate...
  • Every year, researchers make gains in the understanding of cancer, and physicians make gains in the treatment of cancer. As a result, every year, more cancer patients survive their disease. In those ways, 2015 will be no different. What will be different are the specific research discoveries and the specific ad...